nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—CYP2D6—Vinorelbine—ovarian cancer	0.0503	0.255	CbGbCtD
Cephalexin—CYP3A4—Topotecan—ovarian cancer	0.0454	0.23	CbGbCtD
Cephalexin—CYP3A4—Vinorelbine—ovarian cancer	0.032	0.162	CbGbCtD
Cephalexin—CYP3A4—Paclitaxel—ovarian cancer	0.0225	0.114	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—ovarian cancer	0.019	0.0964	CbGbCtD
Cephalexin—CYP3A4—Docetaxel—ovarian cancer	0.0162	0.0822	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—ovarian cancer	0.0121	0.0613	CbGbCtD
Cephalexin—SLC47A1—myometrium—ovarian cancer	0.00629	0.0622	CbGeAlD
Cephalexin—SLC15A1—epithelium—ovarian cancer	0.00526	0.0521	CbGeAlD
Cephalexin—SLC47A1—uterine cervix—ovarian cancer	0.00489	0.0484	CbGeAlD
Cephalexin—SLC15A1—endometrium—ovarian cancer	0.00472	0.0467	CbGeAlD
Cephalexin—SLC47A1—decidua—ovarian cancer	0.00466	0.0461	CbGeAlD
Cephalexin—SLC47A1—endometrium—ovarian cancer	0.00443	0.0438	CbGeAlD
Cephalexin—SLC47A1—gonad—ovarian cancer	0.00411	0.0406	CbGeAlD
Cephalexin—SLC47A1—uterus—ovarian cancer	0.00408	0.0403	CbGeAlD
Cephalexin—SLC47A1—female reproductive system—ovarian cancer	0.00367	0.0363	CbGeAlD
Cephalexin—SLC22A5—myometrium—ovarian cancer	0.00365	0.0361	CbGeAlD
Cephalexin—SLC15A1—vagina—ovarian cancer	0.00354	0.035	CbGeAlD
Cephalexin—SLC47A1—female gonad—ovarian cancer	0.00334	0.033	CbGeAlD
Cephalexin—SLC47A1—vagina—ovarian cancer	0.00332	0.0328	CbGeAlD
Cephalexin—SLC15A2—uterine cervix—ovarian cancer	0.00326	0.0323	CbGeAlD
Cephalexin—SLC47A1—testis—ovarian cancer	0.00296	0.0293	CbGeAlD
Cephalexin—SLC15A2—endometrium—ovarian cancer	0.00295	0.0292	CbGeAlD
Cephalexin—SLC22A5—uterine cervix—ovarian cancer	0.00284	0.0281	CbGeAlD
Cephalexin—SLC22A5—endometrium—ovarian cancer	0.00257	0.0254	CbGeAlD
Cephalexin—SLC15A2—female reproductive system—ovarian cancer	0.00244	0.0242	CbGeAlD
Cephalexin—ALB—testis—ovarian cancer	0.00236	0.0234	CbGeAlD
Cephalexin—SLC15A2—female gonad—ovarian cancer	0.00222	0.022	CbGeAlD
Cephalexin—SLC15A2—vagina—ovarian cancer	0.00221	0.0219	CbGeAlD
Cephalexin—SLC47A1—lymph node—ovarian cancer	0.00214	0.0212	CbGeAlD
Cephalexin—SLC22A5—female reproductive system—ovarian cancer	0.00213	0.021	CbGeAlD
Cephalexin—SLC15A2—testis—ovarian cancer	0.00197	0.0195	CbGeAlD
Cephalexin—SLC22A5—female gonad—ovarian cancer	0.00193	0.0191	CbGeAlD
Cephalexin—SLC22A5—vagina—ovarian cancer	0.00192	0.019	CbGeAlD
Cephalexin—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00172	0.00245	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.00172	0.00245	CcSEcCtD
Cephalexin—SLC22A5—testis—ovarian cancer	0.00172	0.017	CbGeAlD
Cephalexin—ALB—lymph node—ovarian cancer	0.00171	0.0169	CbGeAlD
Cephalexin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.0017	0.00243	CcSEcCtD
Cephalexin—Fatigue—Melphalan—ovarian cancer	0.0017	0.00243	CcSEcCtD
Cephalexin—Nervous system disorder—Vinorelbine—ovarian cancer	0.00169	0.00241	CcSEcCtD
Cephalexin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00169	0.00241	CcSEcCtD
Cephalexin—Skin disorder—Vinorelbine—ovarian cancer	0.00168	0.00239	CcSEcCtD
Cephalexin—Hypersensitivity—Chlorambucil—ovarian cancer	0.00167	0.00238	CcSEcCtD
Cephalexin—Feeling abnormal—Topotecan—ovarian cancer	0.00166	0.00237	CcSEcCtD
Cephalexin—Colitis—Doxorubicin—ovarian cancer	0.00165	0.00235	CcSEcCtD
Cephalexin—Gastrointestinal pain—Topotecan—ovarian cancer	0.00165	0.00235	CcSEcCtD
Cephalexin—Pancytopenia—Docetaxel—ovarian cancer	0.00164	0.00234	CcSEcCtD
Cephalexin—Haemoglobin—Paclitaxel—ovarian cancer	0.00164	0.00234	CcSEcCtD
Cephalexin—Haemorrhage—Paclitaxel—ovarian cancer	0.00163	0.00233	CcSEcCtD
Cephalexin—Asthenia—Chlorambucil—ovarian cancer	0.00162	0.00232	CcSEcCtD
Cephalexin—Vaginal infection—Doxorubicin—ovarian cancer	0.00162	0.00232	CcSEcCtD
Cephalexin—Blood urea increased—Doxorubicin—ovarian cancer	0.00162	0.00232	CcSEcCtD
Cephalexin—Neutropenia—Docetaxel—ovarian cancer	0.00162	0.00231	CcSEcCtD
Cephalexin—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00161	0.0023	CcSEcCtD
Cephalexin—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00161	0.0023	CcSEcCtD
Cephalexin—Connective tissue disorder—Paclitaxel—ovarian cancer	0.0016	0.00229	CcSEcCtD
Cephalexin—Pruritus—Chlorambucil—ovarian cancer	0.0016	0.00228	CcSEcCtD
Cephalexin—Urticaria—Topotecan—ovarian cancer	0.0016	0.00228	CcSEcCtD
Cephalexin—Urethral disorder—Paclitaxel—ovarian cancer	0.0016	0.00228	CcSEcCtD
Cephalexin—Abdominal pain—Topotecan—ovarian cancer	0.00159	0.00227	CcSEcCtD
Cephalexin—Body temperature increased—Topotecan—ovarian cancer	0.00159	0.00227	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00157	0.00224	CcSEcCtD
Cephalexin—Urticaria—Melphalan—ovarian cancer	0.00157	0.00224	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.00155	0.00221	CcSEcCtD
Cephalexin—Diarrhoea—Chlorambucil—ovarian cancer	0.00155	0.00221	CcSEcCtD
Cephalexin—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00154	0.0022	CcSEcCtD
Cephalexin—Erythema multiforme—Paclitaxel—ovarian cancer	0.00154	0.0022	CcSEcCtD
Cephalexin—Infestation NOS—Docetaxel—ovarian cancer	0.00154	0.0022	CcSEcCtD
Cephalexin—Infestation—Docetaxel—ovarian cancer	0.00154	0.0022	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00153	0.00218	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00149	0.00212	CcSEcCtD
Cephalexin—Fatigue—Vinorelbine—ovarian cancer	0.00149	0.00212	CcSEcCtD
Cephalexin—Hypersensitivity—Topotecan—ovarian cancer	0.00149	0.00212	CcSEcCtD
Cephalexin—Immune system disorder—Paclitaxel—ovarian cancer	0.00147	0.0021	CcSEcCtD
Cephalexin—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00146	0.00208	CcSEcCtD
Cephalexin—Hypersensitivity—Melphalan—ovarian cancer	0.00145	0.00207	CcSEcCtD
Cephalexin—Asthenia—Topotecan—ovarian cancer	0.00145	0.00206	CcSEcCtD
Cephalexin—Vomiting—Chlorambucil—ovarian cancer	0.00144	0.00205	CcSEcCtD
Cephalexin—Agranulocytosis—Docetaxel—ovarian cancer	0.00144	0.00205	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00144	0.00205	CcSEcCtD
Cephalexin—Mental disorder—Paclitaxel—ovarian cancer	0.00143	0.00204	CcSEcCtD
Cephalexin—SLC15A2—lymph node—ovarian cancer	0.00143	0.0141	CbGeAlD
Cephalexin—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00143	0.00204	CcSEcCtD
Cephalexin—Pruritus—Topotecan—ovarian cancer	0.00143	0.00203	CcSEcCtD
Cephalexin—Feeling abnormal—Vinorelbine—ovarian cancer	0.00142	0.00203	CcSEcCtD
Cephalexin—Asthenia—Melphalan—ovarian cancer	0.00142	0.00202	CcSEcCtD
Cephalexin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00141	0.00201	CcSEcCtD
Cephalexin—Pruritus—Melphalan—ovarian cancer	0.0014	0.00199	CcSEcCtD
Cephalexin—CYP3A4—female reproductive system—ovarian cancer	0.00139	0.0138	CbGeAlD
Cephalexin—Haemoglobin—Docetaxel—ovarian cancer	0.00139	0.00198	CcSEcCtD
Cephalexin—Haemorrhage—Docetaxel—ovarian cancer	0.00138	0.00197	CcSEcCtD
Cephalexin—Hepatitis—Docetaxel—ovarian cancer	0.00138	0.00197	CcSEcCtD
Cephalexin—Diarrhoea—Topotecan—ovarian cancer	0.00138	0.00197	CcSEcCtD
Cephalexin—CYP2D6—female reproductive system—ovarian cancer	0.00137	0.0136	CbGeAlD
Cephalexin—Urticaria—Vinorelbine—ovarian cancer	0.00137	0.00195	CcSEcCtD
Cephalexin—Urinary tract disorder—Docetaxel—ovarian cancer	0.00137	0.00195	CcSEcCtD
Cephalexin—Abdominal pain—Vinorelbine—ovarian cancer	0.00136	0.00194	CcSEcCtD
Cephalexin—Body temperature increased—Vinorelbine—ovarian cancer	0.00136	0.00194	CcSEcCtD
Cephalexin—Connective tissue disorder—Docetaxel—ovarian cancer	0.00136	0.00194	CcSEcCtD
Cephalexin—Urethral disorder—Docetaxel—ovarian cancer	0.00136	0.00193	CcSEcCtD
Cephalexin—Diarrhoea—Melphalan—ovarian cancer	0.00135	0.00193	CcSEcCtD
Cephalexin—Osteoarthritis—Epirubicin—ovarian cancer	0.00135	0.00192	CcSEcCtD
Cephalexin—Nausea—Chlorambucil—ovarian cancer	0.00135	0.00192	CcSEcCtD
Cephalexin—Dizziness—Topotecan—ovarian cancer	0.00133	0.0019	CcSEcCtD
Cephalexin—Erythema multiforme—Docetaxel—ovarian cancer	0.00131	0.00187	CcSEcCtD
Cephalexin—Agitation—Paclitaxel—ovarian cancer	0.00131	0.00186	CcSEcCtD
Cephalexin—Angioedema—Paclitaxel—ovarian cancer	0.0013	0.00185	CcSEcCtD
Cephalexin—Vomiting—Topotecan—ovarian cancer	0.00128	0.00183	CcSEcCtD
Cephalexin—Leukopenia—Paclitaxel—ovarian cancer	0.00127	0.00181	CcSEcCtD
Cephalexin—Rash—Topotecan—ovarian cancer	0.00127	0.00181	CcSEcCtD
Cephalexin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00127	0.00181	CcSEcCtD
Cephalexin—Dermatitis—Topotecan—ovarian cancer	0.00127	0.00181	CcSEcCtD
Cephalexin—Blood creatinine increased—Epirubicin—ovarian cancer	0.00126	0.0018	CcSEcCtD
Cephalexin—Headache—Topotecan—ovarian cancer	0.00126	0.0018	CcSEcCtD
Cephalexin—Vomiting—Melphalan—ovarian cancer	0.00126	0.00179	CcSEcCtD
Cephalexin—Immune system disorder—Docetaxel—ovarian cancer	0.00125	0.00178	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—ovarian cancer	0.00125	0.00178	CcSEcCtD
Cephalexin—CYP2D6—female gonad—ovarian cancer	0.00125	0.0123	CbGeAlD
Cephalexin—Rash—Melphalan—ovarian cancer	0.00124	0.00177	CcSEcCtD
Cephalexin—SLC22A5—lymph node—ovarian cancer	0.00124	0.0123	CbGeAlD
Cephalexin—Dermatitis—Melphalan—ovarian cancer	0.00124	0.00177	CcSEcCtD
Cephalexin—Asthenia—Vinorelbine—ovarian cancer	0.00124	0.00176	CcSEcCtD
Cephalexin—Convulsion—Paclitaxel—ovarian cancer	0.00123	0.00176	CcSEcCtD
Cephalexin—Pruritus—Vinorelbine—ovarian cancer	0.00122	0.00174	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—ovarian cancer	0.00122	0.00174	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.00122	0.00173	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00122	0.00173	CcSEcCtD
Cephalexin—Mental disorder—Docetaxel—ovarian cancer	0.00121	0.00173	CcSEcCtD
Cephalexin—Arthralgia—Paclitaxel—ovarian cancer	0.00121	0.00173	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.0012	0.00171	CcSEcCtD
Cephalexin—Nausea—Topotecan—ovarian cancer	0.0012	0.00171	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—ovarian cancer	0.00119	0.0017	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00119	0.0017	CcSEcCtD
Cephalexin—Diarrhoea—Vinorelbine—ovarian cancer	0.00118	0.00168	CcSEcCtD
Cephalexin—Nausea—Melphalan—ovarian cancer	0.00117	0.00167	CcSEcCtD
Cephalexin—Confusional state—Paclitaxel—ovarian cancer	0.00117	0.00167	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00117	0.00167	CcSEcCtD
Cephalexin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00116	0.00165	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—ovarian cancer	0.00115	0.00165	CcSEcCtD
Cephalexin—Dizziness—Vinorelbine—ovarian cancer	0.00114	0.00163	CcSEcCtD
Cephalexin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00114	0.00162	CcSEcCtD
Cephalexin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00114	0.00162	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—ovarian cancer	0.00113	0.00161	CcSEcCtD
Cephalexin—Skin disorder—Paclitaxel—ovarian cancer	0.00113	0.00161	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00112	0.0016	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00112	0.0016	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—ovarian cancer	0.00111	0.00158	CcSEcCtD
Cephalexin—CYP2D6—testis—ovarian cancer	0.00111	0.011	CbGeAlD
Cephalexin—Gastritis—Doxorubicin—ovarian cancer	0.00111	0.00158	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.0011	0.00157	CcSEcCtD
Cephalexin—Vomiting—Vinorelbine—ovarian cancer	0.0011	0.00156	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—ovarian cancer	0.00109	0.00155	CcSEcCtD
Cephalexin—Rash—Vinorelbine—ovarian cancer	0.00109	0.00155	CcSEcCtD
Cephalexin—Dermatitis—Vinorelbine—ovarian cancer	0.00109	0.00155	CcSEcCtD
Cephalexin—Headache—Vinorelbine—ovarian cancer	0.00108	0.00154	CcSEcCtD
Cephalexin—Leukopenia—Docetaxel—ovarian cancer	0.00108	0.00154	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—ovarian cancer	0.00107	0.00152	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00106	0.00151	CcSEcCtD
Cephalexin—Convulsion—Docetaxel—ovarian cancer	0.00104	0.00149	CcSEcCtD
Cephalexin—Infestation—Epirubicin—ovarian cancer	0.00104	0.00148	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—ovarian cancer	0.00104	0.00148	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00103	0.00147	CcSEcCtD
Cephalexin—Arthralgia—Docetaxel—ovarian cancer	0.00103	0.00146	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—ovarian cancer	0.00102	0.00146	CcSEcCtD
Cephalexin—Nausea—Vinorelbine—ovarian cancer	0.00102	0.00146	CcSEcCtD
Cephalexin—Dyspepsia—Paclitaxel—ovarian cancer	0.00102	0.00146	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00102	0.00145	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—ovarian cancer	0.00101	0.00144	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.001	0.00143	CcSEcCtD
Cephalexin—Fatigue—Paclitaxel—ovarian cancer	0.001	0.00143	CcSEcCtD
Cephalexin—Confusional state—Docetaxel—ovarian cancer	0.000991	0.00141	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000984	0.0014	CcSEcCtD
Cephalexin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000983	0.0014	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—ovarian cancer	0.00097	0.00138	CcSEcCtD
Cephalexin—Nervous system disorder—Docetaxel—ovarian cancer	0.000964	0.00137	CcSEcCtD
Cephalexin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000963	0.00137	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—ovarian cancer	0.000962	0.00137	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—ovarian cancer	0.000962	0.00137	CcSEcCtD
Cephalexin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000956	0.00136	CcSEcCtD
Cephalexin—Skin disorder—Docetaxel—ovarian cancer	0.000955	0.00136	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000954	0.00136	CcSEcCtD
Cephalexin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000949	0.00135	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—ovarian cancer	0.000938	0.00134	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—ovarian cancer	0.000934	0.00133	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—ovarian cancer	0.000934	0.00133	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—ovarian cancer	0.000922	0.00131	CcSEcCtD
Cephalexin—Urticaria—Paclitaxel—ovarian cancer	0.000922	0.00131	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—ovarian cancer	0.000917	0.00131	CcSEcCtD
Cephalexin—Abdominal pain—Paclitaxel—ovarian cancer	0.000917	0.00131	CcSEcCtD
Cephalexin—Body temperature increased—Paclitaxel—ovarian cancer	0.000917	0.00131	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—ovarian cancer	0.000915	0.0013	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00091	0.0013	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000898	0.00128	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000896	0.00128	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—ovarian cancer	0.000883	0.00126	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—ovarian cancer	0.000868	0.00124	CcSEcCtD
Cephalexin—Dyspepsia—Docetaxel—ovarian cancer	0.000866	0.00123	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—ovarian cancer	0.000864	0.00123	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—ovarian cancer	0.000864	0.00123	CcSEcCtD
Cephalexin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000855	0.00122	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000853	0.00122	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000849	0.00121	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000849	0.00121	CcSEcCtD
Cephalexin—Fatigue—Docetaxel—ovarian cancer	0.000848	0.00121	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—ovarian cancer	0.000847	0.00121	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—ovarian cancer	0.000843	0.0012	CcSEcCtD
Cephalexin—Asthenia—Paclitaxel—ovarian cancer	0.000832	0.00119	CcSEcCtD
Cephalexin—Pruritus—Paclitaxel—ovarian cancer	0.000821	0.00117	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—ovarian cancer	0.000818	0.00117	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000817	0.00116	CcSEcCtD
Cephalexin—Feeling abnormal—Docetaxel—ovarian cancer	0.00081	0.00116	CcSEcCtD
Cephalexin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000804	0.00115	CcSEcCtD
Cephalexin—Diarrhoea—Paclitaxel—ovarian cancer	0.000794	0.00113	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—ovarian cancer	0.00078	0.00111	CcSEcCtD
Cephalexin—Abdominal pain—Docetaxel—ovarian cancer	0.000777	0.00111	CcSEcCtD
Cephalexin—Body temperature increased—Docetaxel—ovarian cancer	0.000777	0.00111	CcSEcCtD
Cephalexin—Dizziness—Paclitaxel—ovarian cancer	0.000767	0.00109	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—ovarian cancer	0.000757	0.00108	CcSEcCtD
Cephalexin—Agitation—Epirubicin—ovarian cancer	0.000747	0.00106	CcSEcCtD
Cephalexin—Vomiting—Paclitaxel—ovarian cancer	0.000738	0.00105	CcSEcCtD
Cephalexin—Rash—Paclitaxel—ovarian cancer	0.000731	0.00104	CcSEcCtD
Cephalexin—Dermatitis—Paclitaxel—ovarian cancer	0.000731	0.00104	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—ovarian cancer	0.000727	0.00104	CcSEcCtD
Cephalexin—Headache—Paclitaxel—ovarian cancer	0.000727	0.00104	CcSEcCtD
Cephalexin—Hypersensitivity—Docetaxel—ovarian cancer	0.000724	0.00103	CcSEcCtD
Cephalexin—Asthenia—Docetaxel—ovarian cancer	0.000706	0.00101	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—ovarian cancer	0.000704	0.001	CcSEcCtD
Cephalexin—Pruritus—Docetaxel—ovarian cancer	0.000696	0.000992	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—ovarian cancer	0.000692	0.000986	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—ovarian cancer	0.000691	0.000985	CcSEcCtD
Cephalexin—Nausea—Paclitaxel—ovarian cancer	0.000689	0.000982	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000687	0.00098	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—ovarian cancer	0.000673	0.00096	CcSEcCtD
Cephalexin—Diarrhoea—Docetaxel—ovarian cancer	0.000673	0.000959	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—ovarian cancer	0.000669	0.000953	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000663	0.000946	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—ovarian cancer	0.000652	0.000929	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—ovarian cancer	0.00065	0.000927	CcSEcCtD
Cephalexin—Dizziness—Docetaxel—ovarian cancer	0.00065	0.000927	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000649	0.000926	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—ovarian cancer	0.000644	0.000918	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—ovarian cancer	0.00064	0.000913	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000636	0.000906	CcSEcCtD
Cephalexin—Vomiting—Docetaxel—ovarian cancer	0.000625	0.000891	CcSEcCtD
Cephalexin—Rash—Docetaxel—ovarian cancer	0.00062	0.000884	CcSEcCtD
Cephalexin—Dermatitis—Docetaxel—ovarian cancer	0.000619	0.000883	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—ovarian cancer	0.000619	0.000882	CcSEcCtD
Cephalexin—Headache—Docetaxel—ovarian cancer	0.000616	0.000878	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000614	0.000875	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000604	0.000861	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000602	0.000858	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000601	0.000857	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—ovarian cancer	0.000596	0.00085	CcSEcCtD
Cephalexin—Nausea—Docetaxel—ovarian cancer	0.000584	0.000833	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—ovarian cancer	0.000584	0.000832	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000573	0.000816	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—ovarian cancer	0.000572	0.000815	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000559	0.000797	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—ovarian cancer	0.000547	0.000779	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000542	0.000773	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—ovarian cancer	0.00054	0.00077	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00053	0.000755	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—ovarian cancer	0.000529	0.000754	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—ovarian cancer	0.000527	0.000751	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—ovarian cancer	0.000524	0.000747	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—ovarian cancer	0.000524	0.000747	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000506	0.000721	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000502	0.000715	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—ovarian cancer	0.000489	0.000697	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—ovarian cancer	0.000488	0.000695	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—ovarian cancer	0.000485	0.000692	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—ovarian cancer	0.000485	0.000692	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—ovarian cancer	0.000476	0.000678	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—ovarian cancer	0.000469	0.000669	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—ovarian cancer	0.000454	0.000647	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000452	0.000645	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—ovarian cancer	0.00044	0.000628	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—ovarian cancer	0.000439	0.000625	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—ovarian cancer	0.000434	0.000619	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—ovarian cancer	0.000422	0.000601	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—ovarian cancer	0.00042	0.000599	CcSEcCtD
Cephalexin—Rash—Epirubicin—ovarian cancer	0.000418	0.000596	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—ovarian cancer	0.000418	0.000596	CcSEcCtD
Cephalexin—Headache—Epirubicin—ovarian cancer	0.000416	0.000592	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—ovarian cancer	0.000406	0.000579	CcSEcCtD
Cephalexin—Nausea—Epirubicin—ovarian cancer	0.000394	0.000562	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—ovarian cancer	0.00039	0.000556	CcSEcCtD
Cephalexin—Rash—Doxorubicin—ovarian cancer	0.000387	0.000552	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—ovarian cancer	0.000387	0.000551	CcSEcCtD
Cephalexin—Headache—Doxorubicin—ovarian cancer	0.000384	0.000548	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—ovarian cancer	0.000365	0.00052	CcSEcCtD
